1 CME Credit
·
Abdominal Radiology, Onco Radiology, Uro-gynaecological
Prostate MRI: Why are we missing clinically significant cancer?
During the webinar we will learn:
• Recognize different causes of missing clinically significant prostate (csPCa) cancer on mpMRI
• Understand the radiobiopathology mechanisms supporting the m/bpMRI visibility and invisibility of csPCa
• Show and review the ambiguities in image interpretation related to PI-RADS 2.1 that might develop false negative results
Already have an account?
Topics Covered
To jump to a specific chapter, click on the chapter title once the video is playing.
00:09 - Introduction to the Webinar
00:39 - Objectives of Prostate Cancer Detection
03:03 - Understanding Missing Prostate Cancer
21:12 - Technical Issues in Prostate MRI
36:08 - Role of Biopsy in Prostate Cancer Detection
38:20 - Common Patterns of Prostate Cancer
50:35 - Challenges in Detecting Prostate Cancer
55:14 - Implications of PIRADS Guidelines
59:03 - Conclusion and Recommendations for Practice
106:00 - Q&A: Role and Reliability of Imaging Techniques
Lecturers
Kai Vilanova M.D. Ph.D.
Spain, Girona
Chief MRI Department. Clínica Girona
Staff consultant. Institute Diagnostic Imaging (IDI). Catalan Institute of Health
Associate Professor. Faculty of Medicine. University of Girona
Author of 105 articles and 22 books and book chapters. Book editor of Atlas of Multiparametric Prostate MRI (Springer 2018). Course director of European Course of Prostate MRI (ESUR 2014). Faculty member and director of the School of MRI courses (ESMRMB). Invited speaker of international meetings. Coordinator of Radiology-Faculty of Medicine-University of Girona.
